Josh Nathan-Kazis

Reporter

AS SEEN ON

Preston's Summary

Josh Nathan-Kazis is a Reporter at various esteemed publications including Barron's, Yahoo Finance, and MarketWatch. He covers a diverse range of topics centered on finance, trading, and healthcare, with a particular focus on markets, the impact of the coronavirus, and wellness-related issues. Josh's insightful work has been featured in outlets such as Yahoo News and Wealth Creation Investing, showcasing his expertise in the intersection of finance and health.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

United States (National)

Coverage Attributes:

Beta
Investment Analysis: 30 %
Cites Data: 26 %
Press Release: 13 %
Government Announcement: 6 %
Private Sector Announcements: 5 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Health News
  • Drugs & Medication
  • Telehealth
  • Mental Health
  • Oncology
  • Remote Healthcare

Pitching Insights

Josh Nathan-Kazis primarily focuses on investment analysis and data-driven reporting within the healthcare and pharmaceutical industry in the United States. He seems to be interested in providing insights into stock performance, market trends, and major company developments.

If you have expert knowledge in the healthcare or pharmaceutical sectors with a focus on stocks, earnings reports, FDA approvals, or other related financial aspects of these industries, your input could be valuable for Josh's coverage.

Consider offering data-backed insights or exclusive information regarding major companies' financial performance or regulatory developments within the U.S. healthcare sector when reaching out to him.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Publications
Most recent topics
Not enough data
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Most recent topics
Not enough data